Ellen Rohde
Corporate Officer/Principal bei VERVE THERAPEUTICS, INC.
Aktive Positionen von Ellen Rohde
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VERVE THERAPEUTICS, INC. | Corporate Officer/Principal | 01.10.2019 | - |
Karriereverlauf von Ellen Rohde
Ehemalige bekannte Positionen von Ellen Rohde
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Corporate Officer/Principal | - | - |
| BIOGEN INC. | Corporate Officer/Principal | - | - |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Ellen Rohde
| University of Cincinnati (Ohio) | Doctorate Degree |
| Universität Leipzig | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Deutschland | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| VERVE THERAPEUTICS, INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Ellen Rohde
- Erfahrung